Entrada Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
TRDA chart
What traders are saying about $TRDA
Latest postsEntrada Therapeutics, Inc. news
- Entrada Therapeutics at Guggenheim: four data readouts loom By Investing.com
Investing.com South Africa ·
- Weekly Recap: DMD trial gains and Q3 financial results
TradingView ·
- Entrada Therapeutics (TRDA) Institutional Ownership 2026 $TRDA
MarketBeat ·
- Roth MKM Maintains Entrada Therapeutics(TRDA.US) With Buy Rating, Cuts Target Price to $10
Moomoo ·
- Entrada Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Entrada Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
marketscreener.com ·
- Entrada Therapeutics Posts $39.7M Q3 Loss, Flags Going-Concern Doubt
Minichart ·
- Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance ·
- Entrada Therapeutics, Inc. (TRDA) Tops Q3 EPS by 7c
StreetInsider ·
- Entrada Therapeutics Reports Q3 2026 Results, $193 Million in Cash
TradingView ·
- Entrada Therapeutics Reports Third Quarter 2026 Financial Results
Yahoo Finance ·
- $193 million in cash and investments is expected to fund Entrada's operations into Q4 2027.
Stock Titan ·
Entrada Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $25.4M | $210.8M | $129.0M | – |
| Net income | -$143.8M | $65.6M | -$6.7M | -$94.6M |
| Diluted EPS | $-3.47 | $1.68 | $-0.20 | $-3.02 |
| Total assets (year end) | $377.4M | $526.3M | $469.2M | $252.1M |
| Cash and equivalents (year end) | $90.4M | $101.2M | $67.6M | $45.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Entrada Therapeutics, Inc.
- Ticker
- TRDA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1689375
- Former names
- CycloPorters, Inc.
Frequently asked questions
What exchange is Entrada Therapeutics, Inc. listed on?
Entrada Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TRDA.
What industry is Entrada Therapeutics, Inc. in?
Entrada Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Entrada Therapeutics, Inc. headquartered?
Entrada Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Entrada Therapeutics, Inc.'s fiscal year end?
Entrada Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Entrada Therapeutics, Inc. report?
Entrada Therapeutics, Inc. reported $25.4M in revenue for calendar year 2025, according to its SEC filings.